PBH
Prestige Consumer Healthcare Inc. NYSE Listed Feb 10, 2005$54.56
Mkt Cap $2.6B
52w Low $51.24
8.7% of range
52w High $89.37
50d MA $60.29
200d MA $63.31
P/E (TTM)
12.8x
EV/EBITDA
14.4x
P/B
1.5x
Debt/Equity
0.6x
ROE
10.9%
P/FCF
17.6x
RSI (14)
—
ATR (14)
—
Beta
0.47
50d MA
$60.29
200d MA
$63.31
Avg Volume
484.4K
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
660 White Plains Road · Tarrytown, NY 10591 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | AMC | 1.16 | 1.14 | -1.7% | 65.55 | +0.2% | +1.2% | -0.3% | +0.9% | +0.6% | +2.2% | — |
| Nov 6, 2025 | AMC | 0.97 | 1.07 | +10.3% | 61.36 | -0.1% | -2.3% | -1.5% | -1.3% | -1.4% | -2.2% | — |
| Aug 7, 2025 | AMC | 1.01 | 0.95 | -5.9% | 67.61 | -0.4% | -3.0% | -5.5% | -3.4% | -1.7% | -4.5% | — |
| May 8, 2025 | AMC | 1.30 | 1.32 | +1.5% | 87.04 | -1.1% | +0.3% | +1.1% | -0.1% | -1.9% | +0.1% | — |
| Feb 6, 2025 | AMC | 1.16 | 1.22 | +5.2% | 87.35 | -0.2% | -0.4% | -0.2% | -1.6% | -3.6% | -1.9% | — |
| Nov 7, 2024 | AMC | 1.08 | 1.09 | +0.9% | 80.09 | +0.4% | +0.3% | +2.1% | +1.9% | +2.8% | +3.4% | — |
| Aug 8, 2024 | AMC | 0.86 | 0.90 | +4.7% | 66.84 | +0.2% | -0.9% | -2.4% | +0.7% | +1.0% | +2.8% | — |
| May 14, 2024 | AMC | 1.14 | 0.98 | -14.0% | 71.47 | -10.7% | -7.0% | -9.1% | -9.5% | -9.5% | -9.0% | — |
| Feb 8, 2024 | AMC | 1.04 | 1.06 | +1.9% | 68.80 | +0.3% | -0.2% | -1.2% | -3.3% | -1.6% | -0.0% | — |
| Nov 2, 2023 | AMC | 1.07 | 1.07 | +0.0% | 59.17 | +1.4% | +0.7% | +0.9% | +1.2% | -0.2% | -2.4% | — |
| Aug 3, 2023 | AMC | 1.01 | 1.06 | +5.0% | 66.52 | -1.0% | +1.2% | +2.7% | -3.4% | -2.2% | -3.5% | — |
| May 4, 2023 | AMC | 1.04 | 1.07 | +2.9% | 62.02 | +0.1% | -2.0% | -4.1% | -5.8% | -5.3% | -5.9% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 2 | Jefferies | Maintains | Hold → Hold | — | $64.47 | $64.15 | -0.5% | +1.5% | -0.1% | +4.0% | +1.7% | +2.9% |
| Nov 7 | Canaccord Genuity | Maintains | Buy → Buy | — | $61.36 | $61.28 | -0.1% | -2.3% | -1.5% | -1.3% | -1.4% | -2.2% |
| Oct 27 | Jefferies | Maintains | Hold → Hold | — | $62.23 | $61.98 | -0.4% | +0.3% | -0.3% | -2.4% | -3.1% | -2.6% |
| Oct 21 | Oppenheimer | Maintains | Outperform → Outperform | — | $62.18 | $61.78 | -0.6% | +0.5% | +1.9% | +0.7% | +0.1% | +0.4% |
| Aug 8 | Canaccord Genuity | Maintains | Buy → Buy | — | $67.61 | $67.31 | -0.4% | -3.0% | -5.5% | -3.4% | -1.7% | -4.5% |
| Mar 21 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $84.36 | $83.71 | -0.8% | -0.2% | +1.2% | +0.8% | +0.8% | +2.0% |
| Feb 13 | Oppenheimer | Maintains | Outperform → Outperform | — | $84.21 | $85.44 | +1.5% | +1.7% | +2.1% | +1.2% | +0.8% | +0.7% |
| Feb 7 | DA Davidson | Maintains | Buy → Buy | — | $87.35 | $87.15 | -0.2% | -0.4% | -0.2% | -1.6% | -3.6% | -1.9% |
| Feb 7 | Canaccord Genuity | Maintains | Buy → Buy | — | $87.35 | $87.15 | -0.2% | -0.4% | -0.2% | -1.6% | -3.6% | -1.9% |
| Nov 11 | DA Davidson | Maintains | Buy → Buy | — | $80.37 | $81.43 | +1.3% | +1.7% | +1.6% | +2.4% | +3.0% | +2.5% |
| Aug 28 | DA Davidson | Maintains | Buy → Buy | — | $72.61 | $72.73 | +0.2% | +1.5% | +1.9% | +2.8% | +2.0% | +4.0% |
| Aug 9 | Canaccord Genuity | Maintains | Buy → Buy | — | $66.84 | $66.97 | +0.2% | -0.9% | -2.4% | +0.7% | +1.0% | +2.8% |
| Aug 9 | DA Davidson | Maintains | Buy → Buy | — | $66.84 | $66.97 | +0.2% | -0.9% | -2.4% | +0.7% | +1.0% | +2.8% |
| Jun 21 | DA Davidson | Upgrade | Neutral → Buy | — | $65.28 | $66.61 | +2.0% | +6.3% | +4.9% | +5.9% | +5.5% | +6.6% |
| May 21 | Canaccord Genuity | Maintains | Buy → Buy | — | $64.70 | $64.70 | +0.0% | +0.5% | +0.0% | -1.3% | -1.1% | -2.3% |
| May 16 | DA Davidson | Maintains | Neutral → Neutral | — | $66.46 | $66.11 | -0.5% | -2.2% | -2.7% | -2.6% | -2.1% | -2.6% |
| Jun 26 | DA Davidson | Maintains | Neutral → Neutral | — | $57.21 | $57.17 | -0.1% | +1.2% | +1.6% | +1.2% | +3.1% | +3.9% |
| May 8 | DA Davidson | Maintains | Neutral → Neutral | — | $60.76 | $60.61 | -0.2% | -2.1% | -3.9% | -3.4% | -4.0% | -2.9% |
| Mar 17 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $61.78 | $61.51 | -0.4% | -0.8% | -0.3% | -0.7% | -1.3% | -1.3% |
| Feb 17 | Oppenheimer | Maintains | Outperform → Outperform | — | $60.76 | $61.41 | +1.1% | +1.2% | +0.6% | +0.1% | +1.7% | +0.2% |
| Jan 13 | Oppenheimer | Maintains | Outperform → Outperform | — | $65.77 | $66.85 | +1.6% | +1.3% | +0.1% | +0.1% | +1.1% | +1.4% |
| Nov 17 | Canaccord Genuity | Maintains | Buy → Buy | — | $58.35 | $58.58 | +0.4% | +0.2% | +2.4% | +2.1% | +4.4% | +2.5% |
| May 10 | Jefferies | Upgrade | Hold → Buy | — | $57.45 | $58.68 | +2.1% | +0.2% | -3.2% | -2.0% | -1.2% | -0.8% |
| May 9 | DA Davidson | Maintains | Neutral → Neutral | — | $54.88 | $55.16 | +0.5% | +4.7% | +4.9% | +1.4% | +2.6% | +3.5% |
| May 9 | Oppenheimer | Upgrade | Perform → Outperform | — | $54.88 | $55.16 | +0.5% | +4.7% | +4.9% | +1.4% | +2.6% | +3.5% |
| Nov 15 | DA Davidson | Maintains | Neutral → Neutral | — | $62.74 | $62.74 | +0.0% | -2.3% | -2.2% | -2.8% | -4.0% | -7.1% |
| Aug 6 | DA Davidson | Maintains | Neutral → Neutral | — | $56.47 | $57.00 | +0.9% | +4.1% | +3.4% | +5.7% | +7.2% | +5.2% |
| May 28 | DA Davidson | Maintains | Neutral → Neutral | — | $50.30 | $50.72 | +0.8% | -0.9% | -0.7% | -0.7% | +0.1% | -0.6% |
| May 10 | DA Davidson | Maintains | Neutral → Neutral | — | $46.10 | $46.75 | +1.4% | +1.6% | +2.2% | +1.1% | +5.4% | +5.2% |
| Nov 6 | DA Davidson | Maintains | Neutral → Neutral | — | $33.68 | $33.70 | +0.1% | -1.9% | +1.2% | +4.8% | +4.6% | +4.6% |
| Aug 7 | DA Davidson | Downgrade | Buy → Neutral | — | $40.79 | $39.81 | -2.4% | -2.1% | -3.0% | -6.4% | -7.4% | -7.5% |
| Mar 26 | Jefferies | Upgrade | Hold → Buy | — | $30.74 | $33.00 | +7.4% | +14.3% | +18.4% | +20.9% | +19.3% | +20.8% |
| Mar 24 | Oppenheimer | Maintains | Perform → Perform | — | $29.50 | $30.98 | +5.0% | +9.7% | +4.2% | +19.2% | +23.4% | +26.0% |
| Mar 19 | DA Davidson | Upgrade | Neutral → Buy | — | $30.00 | $30.60 | +2.0% | +4.4% | +0.6% | -1.7% | +7.8% | +2.5% |
| Nov 4 | DA Davidson | Maintains | Neutral → Neutral | — | $36.93 | $37.41 | +1.3% | +3.7% | +2.5% | +1.8% | +3.1% | +3.5% |
| Jan 15 | Raymond James | Downgrade | Outperform → Market Perform | — | $28.53 | $26.36 | -7.6% | -1.5% | +0.4% | -0.6% | -2.3% | -3.6% |
| May 5 | B. Riley FBR | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| Feb 5 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $35.83 | $35.50 | -0.9% | -0.8% | +4.0% | +3.0% | -1.3% | -5.8% |
| Feb 5 | KeyBanc | Maintains | Overweight → Overweight | — | $35.83 | $35.50 | -0.9% | -0.8% | +4.0% | +3.0% | -1.3% | -5.8% |
| Feb 5 | DA Davidson | Downgrade | Buy → Neutral | — | $35.83 | $35.50 | -0.9% | -0.8% | +4.0% | +3.0% | -1.3% | -5.8% |
| Dec 4 | William Blair | Upgrade | Market Perform → Outperform | — | $44.56 | $46.79 | +5.0% | +7.0% | +5.0% | +5.2% | +4.3% | +4.9% |
| Nov 15 | BMO Capital | Upgrade | Market Perform → Outperform | — | $40.67 | $40.70 | +0.1% | +0.0% | +2.5% | +4.0% | +4.7% | +5.1% |
| Nov 3 | Jefferies | Maintains | Hold → Hold | — | $43.76 | $43.50 | -0.6% | -1.8% | -1.6% | -2.9% | -5.1% | -6.3% |
| May 22 | Raymond James | Upgrade | Market Perform → Outperform | — | $49.39 | $51.66 | +4.6% | +1.6% | +1.2% | +1.2% | +1.6% | +0.9% |
| May 9 | DA Davidson | Maintains | Buy → Buy | — | $56.11 | $56.80 | +1.2% | +2.0% | +1.5% | -4.6% | -6.9% | -8.7% |
| Nov 17 | Gabelli & Co. | Maintains | Buy → Buy | — | $49.83 | $50.67 | +1.7% | +1.0% | -1.4% | -1.6% | -1.7% | -1.6% |
| Mar 7 | KeyBanc | Maintains | Overweight → Overweight | — | $51.28 | $51.08 | -0.4% | +0.8% | +0.1% | +0.8% | +0.5% | +3.2% |
| Feb 5 | PiperJaffray | Maintains | Overweight → Overweight | — | $49.25 | $49.80 | +1.1% | -2.4% | -1.3% | -1.0% | -3.3% | -4.7% |
| Jan 25 | Jefferies | Maintains | Underperform → Underperform | — | $47.26 | $46.95 | -0.7% | -1.8% | -1.0% | -1.4% | -3.4% | -1.2% |
| Nov 30 | Jefferies | Downgrade | Hold → Underperform | — | $54.19 | $53.79 | -0.7% | -6.1% | -3.1% | -1.9% | -5.0% | -3.8% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | Zerillo JeffreyOff | Senior VP Operations | Sell | 1,207 | $54.99 | $66K | 42,820 | -3.76% | — |
| May 5, 2026 | Zerillo JeffreyOff | Senior VP Operations | Sell | 346 | $55.32 | $19K | 44,334 | +0.52% | — |
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
Prestige Consumer Healthcare's new agreement with Foundation Consumer Brands could expand distribution channels or enable product line extensions, potentially driving revenue growth and improving competitive positioning in the consumer health sector.
Mar 20
8-K · 7.01
! Medium
Prestige Consumer Healthcare Inc. -- 8-K 7.01: Regulation FD Disclosure
Prestige Consumer Healthcare (PBH) disclosed Q4 2025 earnings presentation materials to investors, indicating management expects to use these slides in upcoming investor communications and analyst meetings.
Feb 5
Data updated apr 26, 2026 6:49pm
· Source: massive.com